Eldridge Sandra, Ashby Deborah, Bennett Catherine, Wakelin Melanie, Feder Gene
Centre for Health Sciences, Barts and The London School of Medicine and Dentistry, London E1 2AT.
BMJ. 2008 Apr 19;336(7649):876-80. doi: 10.1136/bmj.39517.495764.25. Epub 2008 Mar 25.
To assess aspects of the internal validity of recently published cluster randomised trials and explore the reporting of information useful in assessing the external validity of these trials.
Review of 34 cluster randomised trials in primary care published in 2004 and 2005 in seven journals (British Medical Journal, British Journal of General Practice, Family Practice, Preventive Medicine, Annals of Internal Medicine, Journal of General Internal Medicine, Pediatrics).
National Library of Medicine (Medline) via PubMed.
To assess aspects of internal validity we extracted data on appropriateness of sample size calculations and analyses, methods of identifying and recruiting individual participants, and blinding. To explore reporting of information useful in assessing external validity we extracted data on cluster eligibility, cluster inclusion and retention, cluster generalisability, and the feasibility and acceptability of the intervention to health providers in clusters.
21 (62%) trials accounted for clustering in sample size calculations and 30 (88%) in the analysis; about a quarter were potentially biased because of procedures surrounding recruitment and identification of patients; individual participants were blind to allocation status in 19 (56%) and outcome assessors were blind in 15 (44%). In almost half the reports, information relating to generalisability of clusters was poorly reported, and in two fifths there was no information about the feasibility and acceptability of the intervention.
Cluster randomised trials are essential for evaluating certain types of interventions. Issues affecting their internal validity, such as appropriate sample size calculations and analysis, have been widely disseminated and are now better addressed by researchers. Blinding of those identifying and recruiting patients to allocation status is recommended but is not always carried out. There may be fewer barriers to internal validity in trials in which individual participants are not recruited. External validity seems poorly addressed in many trials, yet is arguably as important as internal validity in judging quality as a basis for healthcare intervention.
评估近期发表的整群随机试验的内部效度方面,并探讨对评估这些试验外部效度有用的信息报告情况。
对2004年和2005年发表在七种期刊(《英国医学杂志》《英国全科医学杂志》《家庭医学》《预防医学》《内科学年鉴》《普通内科学杂志》《儿科学》)上的34项初级保健整群随机试验进行综述。
通过PubMed获取美国国立医学图书馆(Medline)的数据。
为评估内部效度方面,我们提取了关于样本量计算和分析的适当性、识别和招募个体参与者的方法以及盲法的数据。为探讨对评估外部效度有用的信息报告情况,我们提取了关于整群合格性、整群纳入和保留、整群可推广性以及干预对整群中医疗服务提供者的可行性和可接受性的数据。
21项(62%)试验在样本量计算中考虑了整群因素,30项(88%)在分析中考虑了;约四分之一的试验因患者招募和识别程序可能存在偏倚;19项(56%)试验中个体参与者对分配情况不知情,15项(44%)试验中结果评估者不知情。在近一半的报告中,关于整群可推广性的信息报告不佳,五分之二的报告中没有关于干预可行性和可接受性的信息。
整群随机试验对于评估某些类型的干预至关重要。影响其内部效度的问题,如适当的样本量计算和分析,已得到广泛传播,现在研究人员能更好地处理。建议对识别和招募患者的人员隐瞒分配情况,但并非总是如此。在不招募个体参与者的试验中,内部效度的障碍可能较少。许多试验中外部效度似乎未得到充分处理,但在判断作为医疗保健干预基础的质量方面,外部效度与内部效度同样重要。